Cargando…

The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations

BACKGROUND: Approximately 17 % of the human genome is comprised of the Long INterspersed Element-1 (LINE-1 or L1) retrotransposon, the only currently active autonomous family of retroelements. Though L1 elements have helped to shape mammalian genome evolution over millions of years, L1 activity can...

Descripción completa

Detalles Bibliográficos
Autores principales: Kines, Kristine J., Sokolowski, Mark, deHaro, Dawn L., Christian, Claiborne M., Baddoo, Melody, Smither, Madison E., Belancio, Victoria P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837594/
https://www.ncbi.nlm.nih.gov/pubmed/27099633
http://dx.doi.org/10.1186/s13100-016-0064-x
_version_ 1782427880315158528
author Kines, Kristine J.
Sokolowski, Mark
deHaro, Dawn L.
Christian, Claiborne M.
Baddoo, Melody
Smither, Madison E.
Belancio, Victoria P.
author_facet Kines, Kristine J.
Sokolowski, Mark
deHaro, Dawn L.
Christian, Claiborne M.
Baddoo, Melody
Smither, Madison E.
Belancio, Victoria P.
author_sort Kines, Kristine J.
collection PubMed
description BACKGROUND: Approximately 17 % of the human genome is comprised of the Long INterspersed Element-1 (LINE-1 or L1) retrotransposon, the only currently active autonomous family of retroelements. Though L1 elements have helped to shape mammalian genome evolution over millions of years, L1 activity can also be mutagenic and result in human disease. L1 expression has the potential to contribute to genomic instability via retrotransposition and DNA double-strand breaks (DSBs). Additionally, L1 is responsible for structural genomic variations induced by other transposable elements such as Alu and SVA, which rely on the L1 ORF2 protein for their propagation. Most of the genomic damage associated with L1 activity originates with the endonuclease domain of the ORF2 protein, which nicks the DNA in preparation for target-primed reverse transcription. RESULTS: Bioinformatic analysis of full-length L1 loci residing in the human genome identified numerous mutations in the amino acid sequence of the ORF2 endonuclease domain. Some of these mutations were found in residues which were predicted to be phosphorylation sites for cellular kinases. We mutated several of these putative phosphorylation sites in the ORF2 endonuclease domain and investigated the effect of these mutations on the function of the full-length ORF2 protein and the endonuclease domain (ENp) alone. Most of the single and multiple point mutations that were tested did not significantly impact expression of the full-length ORF2p, or alter its ability to drive Alu retrotransposition. Similarly, most of those same mutations did not significantly alter expression of ENp, or impair its ability to induce DNA damage and cause toxicity. CONCLUSIONS: Overall, our data demonstrate that the full-length ORF2p or the ENp alone can tolerate several specific single and multiple point mutations in the endonuclease domain without significant impairment of their ability to support Alu mobilization or induce DNA damage, respectively. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13100-016-0064-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4837594
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48375942016-04-21 The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations Kines, Kristine J. Sokolowski, Mark deHaro, Dawn L. Christian, Claiborne M. Baddoo, Melody Smither, Madison E. Belancio, Victoria P. Mob DNA Research BACKGROUND: Approximately 17 % of the human genome is comprised of the Long INterspersed Element-1 (LINE-1 or L1) retrotransposon, the only currently active autonomous family of retroelements. Though L1 elements have helped to shape mammalian genome evolution over millions of years, L1 activity can also be mutagenic and result in human disease. L1 expression has the potential to contribute to genomic instability via retrotransposition and DNA double-strand breaks (DSBs). Additionally, L1 is responsible for structural genomic variations induced by other transposable elements such as Alu and SVA, which rely on the L1 ORF2 protein for their propagation. Most of the genomic damage associated with L1 activity originates with the endonuclease domain of the ORF2 protein, which nicks the DNA in preparation for target-primed reverse transcription. RESULTS: Bioinformatic analysis of full-length L1 loci residing in the human genome identified numerous mutations in the amino acid sequence of the ORF2 endonuclease domain. Some of these mutations were found in residues which were predicted to be phosphorylation sites for cellular kinases. We mutated several of these putative phosphorylation sites in the ORF2 endonuclease domain and investigated the effect of these mutations on the function of the full-length ORF2 protein and the endonuclease domain (ENp) alone. Most of the single and multiple point mutations that were tested did not significantly impact expression of the full-length ORF2p, or alter its ability to drive Alu retrotransposition. Similarly, most of those same mutations did not significantly alter expression of ENp, or impair its ability to induce DNA damage and cause toxicity. CONCLUSIONS: Overall, our data demonstrate that the full-length ORF2p or the ENp alone can tolerate several specific single and multiple point mutations in the endonuclease domain without significant impairment of their ability to support Alu mobilization or induce DNA damage, respectively. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13100-016-0064-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-19 /pmc/articles/PMC4837594/ /pubmed/27099633 http://dx.doi.org/10.1186/s13100-016-0064-x Text en © Kines et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kines, Kristine J.
Sokolowski, Mark
deHaro, Dawn L.
Christian, Claiborne M.
Baddoo, Melody
Smither, Madison E.
Belancio, Victoria P.
The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations
title The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations
title_full The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations
title_fullStr The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations
title_full_unstemmed The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations
title_short The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations
title_sort endonuclease domain of the line-1 orf2 protein can tolerate multiple mutations
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837594/
https://www.ncbi.nlm.nih.gov/pubmed/27099633
http://dx.doi.org/10.1186/s13100-016-0064-x
work_keys_str_mv AT kineskristinej theendonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT sokolowskimark theendonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT deharodawnl theendonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT christianclaibornem theendonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT baddoomelody theendonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT smithermadisone theendonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT belanciovictoriap theendonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT kineskristinej endonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT sokolowskimark endonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT deharodawnl endonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT christianclaibornem endonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT baddoomelody endonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT smithermadisone endonucleasedomainoftheline1orf2proteincantoleratemultiplemutations
AT belanciovictoriap endonucleasedomainoftheline1orf2proteincantoleratemultiplemutations